Notice: This company has been marked as potentially delisted and may not be actively trading. M.D.C. (MDC) Stock Forecast & Price Target Add Compare Share Share Analyst Forecasts Stock AnalysisAnalyst ForecastsDividendEarningsHeadlinesInsider TradesOwnershipTrends Get the Latest News and Ratings for MDC and Related Stocks Enter your email address to receive the latest news and analysts' ratings for M.D.C. and its competitors. Enter your email to sign up for newsletter Sign Up MDC Analyst Ratings Over TimeTypeCurrent Forecast10/10/23 to 10/9/241 Month Ago9/10/23 to 9/9/243 Months Ago7/12/23 to 7/11/241 Year Ago10/10/22 to 10/10/23Strong Buy0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)0 Strong Buy rating(s)Buy0 Buy rating(s)0 Buy rating(s)0 Buy rating(s)1 Buy rating(s)Hold2 Hold rating(s)2 Hold rating(s)3 Hold rating(s)2 Hold rating(s)Sell1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)1 Sell rating(s)Consensus Price Target$52.50$52.50$52.13$46.17Forecasted Upside-16.64% Downside-16.64% Downside-17.24% Downside14.39% UpsideConsensus RatingReduceReduceReduceHold Musk’s new company could top a trillion? (Ad)The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just released the details on what he’s calling Elon’s Project X-9840. Click here to see the details because there’s not much time to prepare. MDC Analyst Recommendations By MonthAnalyst Ratings Chart DescriptionThe chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.Skip Chart & View Analyst Rating History MDC Price Targets by MonthAverage Share Price and Price Target by Month Chart DescriptionThe chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table M.D.C. Stock vs. The CompetitionTypeM.D.C.Consumer Cyclical CompaniesS&P 500Consensus Rating Score 1.67 2.63 2.50Consensus RatingReduceModerate BuyHoldPredicted Upside-16.64% Downside116.48% Upside7.88% UpsideNews Sentiment RatingNeutral NewsSee Recent MDC NewsNeutral NewsPositive News Recent Analyst Forecasts and Stock Ratings All Ratings Strong Buy Buy Hold Sell Rating Show All Upside > 100% Upside 50% - 100% Upside 20% - 50% Upside 10% - 20% Upside 0% - 10% Downside 0% - 10% Downside 10% - 20% Downside 20% - 50% Downside 50% - 100% Downside > 100% Upside/Downside All Actions Upgrades Downgrades Initiates Coverage Raises Target Lowers Target Reiterates Rating Action Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Years 5 Years Time Frame Start Date End Date Most Recent from Each Brokerage All Show Export to Excel DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails2/7/2024Raymond James4 of 5 stars Reiterated RatingOutperform ➝ Market Perform1/31/2024Evercore ISI2 of 5 stars DowngradeOutperform ➝ In-Line$57.00 ➝ $63.00+0.49%11/2/2023JPMorgan Chase & Co.3 of 5 stars Lower TargetUnderweight ➝ Underweight$41.50 ➝ $39.50-3.80%7/31/2023WedbushSubscribe to MarketBeat All Access for the recommendation accuracy ratingJ. MccanlessSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost TargetNeutral ➝ Neutral$28.00 ➝ $51.00-0.12%6/14/2023Seaport Res PtnSubscribe to MarketBeat All Access for the recommendation accuracy ratingK. ZenerSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingNeutralAnalyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 01:21 AM ET. MDC Forecast - Frequently Asked Questions What is M.D.C.'s forecast for 2024? According to the research reports of 3 Wall Street equities research analysts, the average twelve-month stock price forecast for M.D.C. is $52.50, with a high forecast of $63.00 and a low forecast of $39.50. Should I buy or sell M.D.C. stock right now? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for M.D.C. in the last twelve months. There is currently 1 sell rating and 2 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "reduce" MDC shares. Does M.D.C.'s stock price have much downside? According to analysts, M.D.C.'s stock has a predicted downside of -16.64% based on their 12-month stock forecasts. Do Wall Street analysts like M.D.C. more than its competitors? Analysts like M.D.C. less than other "consumer cyclical" companies. The consensus rating for M.D.C. is Reduce while the average consensus rating for "consumer cyclical" companies is Moderate Buy. Learn more on how MDC compares to other companies. Stock Forecasts and Research Tools Related Companies: Toll Brothers Stock Forecast Meritage Homes Stock Forecast KB Home Stock Forecast M/I Homes Stock Forecast Tri Pointe Homes Stock Forecast Cavco Industries Stock Forecast Hovnanian Enterprises Stock Forecast Beazer Homes USA Stock Forecast D.R. Horton Stock Forecast Lennar Stock Forecast Today's Ratings: U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top Rated Stocks: Top Rated Stocks Top Rated Dividend Stocks Top Rated Small-Cap Stocks Top Rated Tech Stocks Most Upgraded Stocks Most Downgraded Stocks Lowest Rated Stocks More Ratings Tools: Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Oil Prices Surge Due to Israel-Iran Conflict (Ad)Heightened tension in the Middle East has created a huge supply shock to the global oil industry. But… I’ve found a new way to invest in oil right here in the US.All the details are right here. This page (NYSE:MDC) was last updated on 10/9/2024 by MarketBeat.com Staff From Our Partners$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | SponsoredAI Expert Reveals New PickYour Financial Planner Won't Tell You About This Investment Strategy Silicon Valley insider Jeff Brown has ...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | SponsoredThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in...Manward Press | SponsoredThese 5 stocks could soar after November 4thHow to Trade this Crazy Election Year? Simple – Just Focus on These 5 stocks… Now available – a free report...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding M.D.C. Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share M.D.C. With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
